Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Catumaxomab [USAN:INN]
RN: 509077-98-9
UNII: M2HPV837HO

Note

  • Used in the treatment of malignant ascites in patients with metastatic cancers; binds EpCAM and CD3 antigens. Extracorporeal PBMNC coating with catumaxomab may be an option to control intravascular cytokine release induced by therapeutic antibodies.

Molecular Formula

  • Unspecified
 

Classification Code

  • Gastrointestinal Agents
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Catumaxomab
  • Catumaxomab [USAN:INN]

Synonyms

  • Catumaxomab
  • Immunoglobulin G2a, anti-(human antigen 17-1A) (mouse monoclonal Ho-3/TP-A-01/TPBs01 heavy chain), disulfide with mouse monoclonal Ho-3/TP-A-01/TPBs01 light chain, disulfide with immunoglobulin G2b anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs01 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs01 light chain
  • Removab
  • UNII-M2HPV837HO

Registry Numbers

CAS Registry Number

  • 509077-98-9

FDA UNII

  • M2HPV837HO

System Generated Number

  • 0509077989